(Q35561009)

8 August 2017

1 reference

title

Are predictive factors clinically useful in bone marrow transplantation? (English)

1 reference

8 August 2017

B. J. Bolwell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561984

21 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://www.nature.com/articles/1704267.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561984

https://www.nature.com/articles/1704267

21 March 2024

1 reference

DOI

10.1038/SJ.BMT.1704267

https://api.crossref.org/works/10.1038/SJ.BMT.1704267

https://www.nature.com/articles/1704267.pdf

21 March 2024

file format

Portable Document Format

1 reference

DOI

10.1038/SJ.BMT.1704267

https://api.crossref.org/works/10.1038/SJ.BMT.1704267

Bone Marrow Transplantation

21 March 2024

published in

1 reference

8 August 2017

volume

32

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

853-861

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704267

8 August 2017

exact match

0 references

cites work

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Favourable outcome of patients older than 40 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Predictive value of pulmonary function tests before marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Pulmonary complications of bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

Marrow transplantation for the treatment of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Outcome after allogeneic bone marrow transplant for leukemia in older adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Successful allogeneic bone marrow transplantation in selected patients over 50 years of age--a single institution's experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Risk factors for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Predictive Factors in Chronic Graft-Versus-Host Disease in Patients with Aplastic Anemia Treated by Marrow Transplantation from HLA-Identical Siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Predictive value of left ventricular ejection fraction in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704267

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704267

1 reference

Dimensions Publication ID

8 August 2017

1045264212

0 references

Fatcat ID

release_sgzyctj2freu5irqyvygyvs46a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sgzyctj2freu5irqyvygyvs46a

24 November 2022

mapped directly with Wikidata item

1 reference